RRC ID 51639
著者 He P, Fu J, Wang DA.
タイトル Murine pluripotent stem cells derived scaffold-free cartilage grafts from a micro-cavitary hydrogel platform.
ジャーナル Acta Biomater
Abstract UNLABELLED:By means of appropriate cell type and scaffold, tissue-engineering approaches aim to construct grafts for cartilage repair. Pluripotent stem cells especially induced pluripotent stem cells (iPSCs) are of promising cell candidates due to the pluripotent plasticity and abundant cell source. We explored three dimensional (3D) culture and chondrogenesis of murine iPSCs (miPSCs) on an alginate-based micro-cavity hydrogel (MCG) platform in pursuit of fabricating synthetic-scaffold-free cartilage grafts. Murine embryonic stem cells (mESCs) were employed in parallel as the control. Chondrogenesis was fulfilled using a consecutive protocol via mesoderm differentiation followed by chondrogenic differentiation; subsequently, miPSC and mESC-seeded constructs were further respectively cultured in chondrocyte culture (CC) medium. Alginate phase in the constructs was then removed to generate a graft only comprised of induced chondrocytic cells and cartilaginous extracellular matrix (ECMs). We found that from the mESC-seeded constructs, formation of intact grafts could be achieved in greater sizes with relatively fewer chondrocytic cells and abundant ECMs; from miPSC-seeded constructs, relatively smaller sized cartilaginous grafts could be formed by cells with chondrocytic phenotype wrapped by abundant and better assembled collagen type II. This study demonstrated successful creation of pluripotent stem cells-derived cartilage/chondroid graft from a 3D MCG interim platform. By the support of materials and methodologies established from this study, particularly given the autologous availability of iPSCs, engineered autologous cartilage engraftment may be potentially fulfilled without relying on the limited and invasive autologous chondrocytes acquisition.
STATEMENT OF SIGNIFICANCE:In this study, we explored chondrogenic differentiation of pluripotent stem cells on a 3D micro-cavitary hydrogel interim platform and creation of pluripotent stem cells-derived cartilage/chondroid graft via a consecutive procedure. Our results demonstrated chondrogenic differentiation could be realized on the platform via mesoderm differentiation. The mESCs/miPSCs derived chondrocytic cells were further cultured to finally generate a pluripotent stem cells-derived scaffold-free construct based on the micro-cavitary hydrogel platform, in which alginate hydrogel could be removed finally. Our results showed that miPSC-derived graft could be formed by cells with chondrocytic phenotype wrapped by abundant and assembled collagen type II. To our knowledge, this study is the first study that initials from pluripotent stem cell seeding on 3D scaffold environment and ends with a scaffold-free chondrogenic micro-tissue. By the support of materials and methodologies established from this study, engineered autologous iPSC-derived cartilage engraftment may be potentially developed instead of autologous chondrocytes grafts that have limited source.
巻・号 35
ページ 87-97
公開日 2016-4-15
DOI 10.1016/j.actbio.2016.02.026
PII S1742-7061(16)30069-1
PMID 26911880
MeSH Animals Cartilage / cytology* Cell Differentiation / drug effects Cell Proliferation / drug effects Cell Survival / drug effects Chondrogenesis / drug effects Gene Expression Regulation / drug effects Hydrogel, Polyethylene Glycol Dimethacrylate / pharmacology* Immunohistochemistry Mesoderm / cytology Mice Mouse Embryonic Stem Cells / cytology Mouse Embryonic Stem Cells / drug effects Pluripotent Stem Cells / cytology* Pluripotent Stem Cells / drug effects Tissue Engineering / methods* Tissue Scaffolds / chemistry*
IF 7.242
引用数 7
リソース情報
ヒト・動物細胞 iPS-MEF-Fb/Ng-440A-3(APS0003)